NCT06619145View on ClinicalTrials.gov

1.Comparison of the Analgesic Effect of Remifentanil Group and Different Dose Groups of Oliceridine in Postoperative Patients Undergoing Cardiac Surgery 2.Exploring the Hemodynamic Effects of Analgesic Regimens With Different Doses of Oliceridine After Cardiac Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 30, 2026

Study Completion Date

October 30, 2026

Conditions
OliceridinePostoperative Cardiac Surgery
Interventions
DRUG

Low dose Oliceridine

Low dose Oliceridine

DRUG

High dose Oliceridine

High dose Oliceridine

Trial Locations (2)

210006

Nanjing First Hospital, Nanjing

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT06619145 - 1.Comparison of the Analgesic Effect of Remifentanil Group and Different Dose Groups of Oliceridine in Postoperative Patients Undergoing Cardiac Surgery 2.Exploring the Hemodynamic Effects of Analgesic Regimens With Different Doses of Oliceridine After Cardiac Surgery | Biotech Hunter | Biotech Hunter